High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system

Allen M. Gown, Lynn C. Goldstein, Todd S. Barry, Steven J. Kussick, Patricia L. Kandalaft, Patricia M. Kim, Christopher C. Tse

Research output: Contribution to journalArticlepeer-review

80 Scopus citations

Fingerprint

Dive into the research topics of 'High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system'. Together they form a unique fingerprint.

Medicine & Life Sciences